Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response ...

The model proposed in this paper hypothesises that the pathology and the response to treatment are different in these presentations, and that interventions should be tailored to the pathology.

FibroNest digital pathology in liver biopsies from patients with MASH FibroNest digital pathology augmented image for ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

An international collaboration led by the University of Gothenburg report that cerebrospinal fluid biomarkers associated with ...

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal ...

FibroMAP combines the power of high-resolution, single-fiber, and spatially resolved datasets generated by PharmaNest's digital pathology and image analysis platform (FibroNest) with advanced ...

In 2019, reports of a rapidly progressive dementia cluster in New Brunswick raised public and media concerns about a ...

Key Poster Highlights: Denifanstat demonstrated antifibrotic effect in qFibrosis-based collagen features previously linked to major adverse liver outcomes (MALO) using digital pathology techniques ...

The Moroccan Association for Prostate Health revealed that prostate cancer ranks as the second most common cancer affecting ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...